News at CenExel

Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™

Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours - ZYNRELEF is the first and only FDA-approved extended-release dual-acting local anesthetic, clinically proven to manage pain and to...

Investigational Clostridium Difficile Vaccine Press Release

JBR Clinical Research is proud to be participating in the clinical trial for an investigational Clostridium Difficile vaccine. In a press release from May 19, 2014, the following positive results were reported: "C. diff infection threatens the many people who...

Translate »